• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 A5 杂合致病性变异患者纵向甘油三酯表型的变异性。

Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants.

机构信息

Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

出版信息

J Clin Lipidol. 2023 Sep-Oct;17(5):659-665. doi: 10.1016/j.jacl.2023.08.003. Epub 2023 Aug 7.

DOI:10.1016/j.jacl.2023.08.003
PMID:37586912
Abstract

BACKGROUND

Biallelic pathogenic variants in APOA5 are an infrequent cause of familial chylomicronemia syndrome characterized by severe, refractory hypertriglyceridemia (HTG), and fasting plasma triglyceride (TG) >10 mmol/L (>875 mg/dL). The TG phenotype of heterozygous individuals with one copy of a pathogenic APOA5 variant is less familiar. We evaluated the longitudinal TG phenotype of individuals with a single pathogenic APOA5 variant allele.

METHODS

Medically stable outpatients from Ontario, Canada were selected for study based on having: 1) a rare pathogenic APOA5 variant in a single allele; and 2) at least three serial fasting TG measurements obtained over >1.5 years of follow-up.

RESULTS

Seven patients were followed for a mean of 5.3 ± 3.7 years. Fasting TG levels varied widely both within and between patients. Three patients displayed at least one normal TG measurement (<2.0 mmol/L or <175 mg/dL). All patients displayed mild-to-moderate HTG (2 to 9.9 mmol/L or 175 to 875 mg/dL) at multiple time points. Five patients displayed at least one severe HTG measurement. 10%, 54%, and 36% of all TG measurements were in normal, mild-to-moderate, and severe HTG ranges, respectively.

CONCLUSIONS

Heterozygosity for pathogenic variants in APOA5 is associated with highly variable TG phenotypes both within and between patients. Heterozygosity confers susceptibility to elevated TG levels, with secondary factors likely modulating the phenotypic severity.

摘要

背景

载脂蛋白 A5(APOA5)的双等位致病性变异是家族性乳糜微粒血症综合征的一个不常见病因,其特征为严重、难治性高甘油三酯血症(HTG),空腹血浆甘油三酯(TG)>10mmol/L(>875mg/dL)。具有一个致病性 APOA5 变异等位基因的杂合子个体的 TG 表型不太常见。我们评估了具有单拷贝致病性 APOA5 变异等位基因的个体的 TG 表型的纵向变化。

方法

根据以下标准,从加拿大安大略省的稳定门诊患者中选择研究对象:1)单个等位基因中存在罕见的致病性 APOA5 变异;2)在>1.5 年的随访中至少有 3 次连续的空腹 TG 测量值。

结果

7 例患者的平均随访时间为 5.3±3.7 年。空腹 TG 水平在患者内和患者间均有很大差异。3 例患者至少有一次 TG 测量值正常(<2.0mmol/L 或<175mg/dL)。所有患者在多个时间点均表现出轻至中度 HTG(2 至 9.9mmol/L 或 175 至 875mg/dL)。5 例患者至少有一次严重 HTG 测量值。所有 TG 测量值中,分别有 10%、54%和 36%处于正常、轻至中度和严重 HTG 范围内。

结论

APOA5 致病性变异的杂合性与患者内和患者间的 TG 表型均高度可变相关。杂合性导致 TG 水平升高易感性增加,继发性因素可能调节表型严重程度。

相似文献

1
Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants.载脂蛋白 A5 杂合致病性变异患者纵向甘油三酯表型的变异性。
J Clin Lipidol. 2023 Sep-Oct;17(5):659-665. doi: 10.1016/j.jacl.2023.08.003. Epub 2023 Aug 7.
2
The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants.具有脂蛋白脂肪酶(LPL)致病性变异的杂合子的纵向甘油三酯表型。
J Clin Lipidol. 2023 Jan-Feb;17(1):87-93. doi: 10.1016/j.jacl.2022.11.007. Epub 2022 Nov 22.
3
Genetic variation in apolipoprotein A-V in hypertriglyceridemia.载脂蛋白 A-V 基因变异与高甘油三酯血症。
Curr Opin Lipidol. 2024 Apr 1;35(2):66-77. doi: 10.1097/MOL.0000000000000916. Epub 2023 Dec 20.
4
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.儿童严重高甘油三酯血症的偶然发现。影响血浆甘油三酯的基因中多种罕见变异的作用。
J Clin Lipidol. 2017 Nov-Dec;11(6):1329-1337.e3. doi: 10.1016/j.jacl.2017.08.017. Epub 2017 Sep 4.
5
Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia.遗传决定严重高甘油三酯血症的特定种族特征。
J Clin Lipidol. 2021 Jan-Feb;15(1):88-96. doi: 10.1016/j.jacl.2020.11.007. Epub 2020 Nov 24.
6
Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.甘油三酯相关基因的罕见变异增加多因素乳糜微粒血症综合征的胰腺炎风险。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3473-e3482. doi: 10.1210/clinem/dgab360.
7
Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.2010-2020 年哥伦比亚佩雷拉家族性乳糜微粒血症综合征分析:一项横断面研究。
Lipids Health Dis. 2023 Mar 28;22(1):43. doi: 10.1186/s12944-022-01768-x.
8
Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia.在严重高甘油三酯血症患者中发现 APOA5 基因的两个新的罕见变异。
Clin Chim Acta. 2011 Nov 20;412(23-24):2194-8. doi: 10.1016/j.cca.2011.08.001. Epub 2011 Aug 7.
9
Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia - Case Report and Literature Review.鉴定一名严重高甘油三酯血症患者的 LMF1 复合杂合变异 - 病例报告和文献复习。
J Atheroscler Thromb. 2024 Jul 1;31(7):1106-1111. doi: 10.5551/jat.64697. Epub 2024 Mar 9.
10
Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.载脂蛋白 LPL、APOA5 和 APOE 变异组合对甘油三酯水平和高甘油三酯血症的附加效应:ICARIA 遗传子研究的结果。
BMC Med Genet. 2010 Apr 29;11:66. doi: 10.1186/1471-2350-11-66.

引用本文的文献

1
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology.持续性乳糜微粒血症的识别与管理:美国国家脂质协会和美国预防心脏病学会联合专家临床共识
Am J Prev Cardiol. 2025 Mar 28;22:100978. doi: 10.1016/j.ajpc.2025.100978. eCollection 2025 Jun.
2
What is the phenotype of heterozygous lipoprotein lipase deficiency?杂合子脂蛋白脂肪酶缺乏症的表型是什么?
Curr Opin Lipidol. 2025 Apr 1;36(2):96-103. doi: 10.1097/MOL.0000000000000974. Epub 2025 Jan 15.
3
Lipoprotein Lipase: Structure, Function, and Genetic Variation.
脂蛋白脂肪酶:结构、功能及基因变异
Genes (Basel). 2025 Jan 5;16(1):55. doi: 10.3390/genes16010055.
4
Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications.原发性高脂血症与2型糖尿病之间的相互作用:治疗意义。
Diabetes Ther. 2024 Sep;15(9):1979-2000. doi: 10.1007/s13300-024-01626-2. Epub 2024 Jul 30.
5
Genetic variation in apolipoprotein A-V in hypertriglyceridemia.载脂蛋白 A-V 基因变异与高甘油三酯血症。
Curr Opin Lipidol. 2024 Apr 1;35(2):66-77. doi: 10.1097/MOL.0000000000000916. Epub 2023 Dec 20.